AAAAAA

   
Results: 1-9 |
Results: 9
Graph models of oncogenesis with an application to melanoma
Authors: Radmacher, MD Simon, R Desper, R Taetle, R Schaffer, AA Nelson, MA
Citation: Md. Radmacher et al., Graph models of oncogenesis with an application to melanoma, J THEOR BIO, 212(4), 2001, pp. 535-548
Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis
Authors: Simon, R Desper, R Papadimitriou, CH Peng, A Alberts, DS Taetle, R Trent, JM Schaffer, AA
Citation: R. Simon et al., Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis, GENE CHROM, 28(1), 2000, pp. 106-120
Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases
Authors: Nelson, MA Radmacher, MD Simon, R Aickin, M Yang, JM Panda, L Emerson, J Roe, D Adair, L Thompson, F Bangert, J Leong, SPL Taetle, R Salmon, S Trent, J
Citation: Ma. Nelson et al., Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases, CANC GENET, 122(2), 2000, pp. 101-109
Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases
Authors: Taetle, R Aickin, M Yang, LM Panda, L Emerson, J Roe, D Adair, L Thompson, F Liu, Y Wisner, L Davis, JR Trent, J Alberts, DS
Citation: R. Taetle et al., Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases, GENE CHROM, 25(3), 1999, pp. 290-300
Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases
Authors: Taetle, R Aickin, M Panda, L Emerson, L Roe, D Thompson, F Davis, L Trent, L Alberts, D
Citation: R. Taetle et al., Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases, GENE CHROM, 25(1), 1999, pp. 46-52
Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines
Authors: Kelner, MJ McMorris, TC Montoya, MA Estes, L Uglik, SF Rutherford, M Samson, KM Bagnell, RD Taetle, R
Citation: Mj. Kelner et al., Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines, CANC CHEMOT, 44(3), 1999, pp. 235-240
Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanoma
Authors: Zhang, J Glatfelter, AA Taetle, R Trent, JM
Citation: J. Zhang et al., Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanoma, CANC GENET, 111(2), 1999, pp. 119-123
Abnormalities in the p34(cdc2)-related PITSLRE protein kinase gene complex(CDC2L) on chromosome band 1p36 in melanoma
Authors: Nelson, MA Ariza, ME Yang, JM Thompson, FH Taetle, R Trent, JM Wymer, J Massey-Brown, K Broome-Powell, M Easton, J Lahti, JM Kidd, VJ
Citation: Ma. Nelson et al., Abnormalities in the p34(cdc2)-related PITSLRE protein kinase gene complex(CDC2L) on chromosome band 1p36 in melanoma, CANC GENET, 108(2), 1999, pp. 91-99
Limited erythropoietic response to combined treatment with recombinant human interleukin 3 and erythropoietin in myelodysplastic syndrome
Authors: Miller, AM Noyes, WE Taetle, R List, AF
Citation: Am. Miller et al., Limited erythropoietic response to combined treatment with recombinant human interleukin 3 and erythropoietin in myelodysplastic syndrome, LEUK RES, 23(1), 1999, pp. 77-83
Risultati: 1-9 |